Mechanism of action of dantroline is?
Dantroline... I'm trying to remember. There's another drug, dantrolene, which is used for malignant hyperthermia and spasticity. Its mechanism is inhibiting calcium release from the sarcoplasmic reticulum. Wait, is dantroline the same as dantrolene? Or is that a typo? Maybe the user made a typo. Let me check that. If it's dantrolene, then the mechanism is well-known. Dantrolene works by inhibiting the release of calcium from the sarcoplasmic reticulum in muscle cells, which reduces muscle contraction. So if the question is about dantroline, perhaps it's a misspelling of dantrolene.
Assuming that's the case, the correct answer would involve the sarcoplasmic reticulum and calcium. Let me verify. Dantrolene's primary action is indeed on the sarcoplasmic reticulum, specifically by inhibiting the ryanodine receptor, which is the calcium release channel. This prevents calcium from being released into the cytoplasm, thereby decreasing muscle contraction. So the core concept here is the role of calcium in muscle contraction and how dantrolene interferes with that process.
Now, looking at the options, even though they aren't listed, the correct answer would be related to inhibiting calcium release from the sarcoplasmic reticulum. The incorrect options would likely be other mechanisms like acting on GABA receptors (like some other muscle relaxants), blocking sodium channels (like local anesthetics), or inhibiting acetylcholine release (like botulinum toxin).
Clinical pearl: Dantrolene is the only drug that directly affects skeletal muscle by inhibiting calcium release, making it unique compared to other muscle relaxants that act centrally. Students should remember that dantrolene is used for malignant hyperthermia and spasticity, and its mechanism is distinct from other muscle relaxants.
**Core Concept**
Dantrolene (likely intended as "dantroline") is a skeletal muscle relaxant that acts directly on muscle fibers. It inhibits calcium release from the sarcoplasmic reticulum via blockade of ryanodine receptors, reducing cytoplasmic calcium and muscle contraction.
**Why the Correct Answer is Right**
Dantrolene’s mechanism involves binding to ryanodine receptors on the sarcoplasmic reticulum, preventing calcium ion release into the cytoplasm. This reduces calcium-mediated cross-bridge cycling in myosin and actin, decreasing muscle contraction. Unlike centrally acting muscle relaxants (e.g., baclofen), dantrolene targets the muscle cell itself.
**Why Each Wrong Option is Incorrect**
**Option A:** *GABA receptor agonism* – Incorrect; dantrolene does not act on GABA receptors. Central agents like baclofen or diazepam modulate GABAergic pathways.